Face coverings for the public: Laying straw men to rest.


Journal

Journal of evaluation in clinical practice
ISSN: 1365-2753
Titre abrégé: J Eval Clin Pract
Pays: England
ID NLM: 9609066

Informations de publication

Date de publication:
08 2020
Historique:
received: 28 04 2020
revised: 05 05 2020
accepted: 06 05 2020
pubmed: 27 5 2020
medline: 7 8 2020
entrez: 27 5 2020
Statut: ppublish

Résumé

Background This article responds to one by Graham Martin and colleagues, who offered a critique of my previous publications on face coverings for the lay public in the Covid-19 pandemic. Their paper reflects criticisms that have been made of face coverings policies more generally. Method Narrative rebuttal. Results I address charges that my coauthors and I had misapplied the precautionary principle; drawn conclusions that were not supported by empirical research; and failed to take account of potential harms But before that, I remind my critics that the evidence on face coverings goes beyond the contested trials and observational studies they place centre stage. I set out some key findings from basic science, epidemiology, mathematical modelling, case studies, and natural experiments, and use this rich and diverse body of evidence as the backdrop for my rebuttal of their narrowly framed objections. I challenge my critics' apparent assumption that a particular kind of systematic review should be valorised over narrative and real-world evidence, since stories are crucial to both our scientific understanding and our moral imagination. Conclusion I conclude by thanking my academic adversaries for the intellectual sparring match, but exhort them to remember our professional accountability to a society in crisis. It is time to lay straw men to rest and embrace the full range of evidence in the context of the perilous threat the world is now facing.

Identifiants

pubmed: 32455503
doi: 10.1111/jep.13415
pmc: PMC8581764
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1070-1077

Subventions

Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Wellcome Trust
ID : WT104830MA
Pays : United Kingdom
Organisme : National Institute for Health Research
ID : BRC-1215-20008
Pays : International

Commentaires et corrections

Type : CommentIn

Informations de copyright

© 2020 The Author. Journal of Evaluation in Clinical Practice published by John Wiley & Sons Ltd.

Références

Emerg Infect Dis. 2006 Jun;12(6):1033-4
pubmed: 16752475
Am J Prev Med. 2016 Sep;51(3):373-83
pubmed: 27130864
PLoS One. 2010 Nov 17;5(11):e13998
pubmed: 21103330
Influenza Other Respir Viruses. 2012 Sep;6(5):313-7
pubmed: 22151080
Nat Med. 2020 May;26(5):676-680
pubmed: 32371934
J Adv Nurs. 2000 Jul;32(1):243-8
pubmed: 10886457
Ann Occup Hyg. 2010 Oct;54(7):789-98
pubmed: 20584862
East Mediterr Health J. 2006 May-Jul;12(3-4):300-9
pubmed: 17037698
PLoS One. 2012;7(1):e29744
pubmed: 22295066
Am J Infect Control. 2008 May;36(4):276-82
pubmed: 18455048
Int J Prev Med. 2013 Sep;4(9):1030-5
pubmed: 24130944
Can J Vet Res. 1998 Jan;62(1):44-8
pubmed: 9442939
Dermatol Ther. 2020 Jul;33(4):e13310
pubmed: 32170800
BMJ. 2020 Apr 9;369:m1435
pubmed: 32273267
J Epidemiol Community Health. 2020 Feb;74(2):203-208
pubmed: 31744848
Lancet. 2020 Apr 16;:
pubmed: 32305074
Nat Med. 2020 Apr;26(4):450-452
pubmed: 32284615
Disaster Med Public Health Prep. 2013 Aug;7(4):413-8
pubmed: 24229526
Clin Infect Dis. 2018 Aug 16;67(5):676-686
pubmed: 29509889
Int J Antimicrob Agents. 2020 Mar;55(3):105924
pubmed: 32081636
J Eval Clin Pract. 2020 Aug;26(4):1070-1077
pubmed: 32455503
N Engl J Med. 2020 May 28;382(22):2158-2160
pubmed: 32329972
Prev Med Rep. 2016 Dec 06;5:86-91
pubmed: 27981021
Emerg Infect Dis. 2009 Feb;15(2):233-41
pubmed: 19193267
Inj Prev. 2000 Jun;6(2):82-90
pubmed: 10875661
J Hyg (Lond). 1946 Sep;44(6):471-9
pubmed: 20475760
Public Health Rep. 2010 Mar-Apr;125(2):178-91
pubmed: 20297744
J Infect Dis. 2010 Feb 15;201(4):491-8
pubmed: 20088690
Hum Vaccin Immunother. 2016 Jun 2;12(6):1435-50
pubmed: 26864126
Contact Dermatitis. 2020 Aug;83(2):145-147
pubmed: 32297349
J Infect Public Health. 2020 Mar;13(3):414-417
pubmed: 32144018
Contact Dermatitis. 2019 Aug;81(2):130-132
pubmed: 30809819
PLoS One. 2008 May 07;3(5):e2101
pubmed: 18461182
PLoS One. 2016 Feb 03;11(2):e0148448
pubmed: 26840614
Emerg Infect Dis. 2004 Feb;10(2):235-43
pubmed: 15030689
Emerg Infect Dis. 2013;19(9):
pubmed: 23968983
PLoS One. 2008 Jul 09;3(7):e2618
pubmed: 18612429
J Travel Med. 2010 Mar-Apr;17(2):82-8
pubmed: 20412173
Int J Infect Dis. 2016 Jun;47:105-11
pubmed: 27044522
JAMA. 2020 May 12;323(18):1837-1838
pubmed: 32215590
BMC Infect Dis. 2012 Jan 26;12:26
pubmed: 22280120
Emerg Infect Dis. 2004 Apr;10(4):587-92
pubmed: 15200846
J Travel Med. 2020 Mar 13;27(2):
pubmed: 32052846
Euro Surveill. 2020 Dec;25(49):
pubmed: 33303066
Int J Health Sci (Qassim). 2018 Sep-Oct;12(5):44-50
pubmed: 30202407
N Engl J Med. 2020 May 21;382(21):2061-2063
pubmed: 32294341
JAMA. 2020 Jun 9;323(22):2252-2253
pubmed: 32347911
Saudi Med J. 2012 Aug;33(8):879-86
pubmed: 22886122
ACS Nano. 2020 May 26;14(5):6339-6347
pubmed: 32329337
BMJ Open. 2016 Dec 30;6(12):e012330
pubmed: 28039289
J Aerosol Med. 1997 Summer;10(2):105-16
pubmed: 10168531
N Engl J Med. 2020 Apr 16;382(16):1564-1567
pubmed: 32182409
BMC Med. 2018 Jun 20;16(1):95
pubmed: 29921272
BMJ. 2001 Sep 15;323(7313):625-8
pubmed: 11557716
Ann Intern Med. 2009 Oct 6;151(7):437-46
pubmed: 19652172
CMAJ. 2020 Apr 14;192(15):E410
pubmed: 32392504
Influenza Other Respir Viruses. 2011 Jul;5(4):256-67
pubmed: 21651736
Emerg Infect Dis. 2004 Feb;10(2):210-6
pubmed: 15030685
Eur J Clin Invest. 2018 Jun;48(6):e12931
pubmed: 29578574
J Travel Med. 2012 May-Jun;19(3):163-8
pubmed: 22530823

Auteurs

Trisha Greenhalgh (T)

Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH